483
Patrick Clarke, M.D.FDA 483 - Patrick Clarke, M.D. - May 01, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Patrick Clarke, M.D. in Los Angeles revealed significant deficiencies in the conduct of a clinical study. The firm failed to adhere to the investigational plan and protocol, including not reporting adverse events and numerous protocol deviations. These issues indicate a lack of proper oversight and execution during the clinical trial.
Open in Dashboard
ID · 0c1f3d42-0ebd-40a7-b278-bcf4a58560bb